Xiaoxiang Mao

1.1k total citations
15 papers, 903 citations indexed

About

Xiaoxiang Mao is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Xiaoxiang Mao has authored 15 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in Xiaoxiang Mao's work include Adipokines, Inflammation, and Metabolic Diseases (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Mitochondrial Function and Pathology (2 papers). Xiaoxiang Mao is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Mitochondrial Function and Pathology (2 papers). Xiaoxiang Mao collaborates with scholars based in China, United Kingdom and United States. Xiaoxiang Mao's co-authors include Kai Huang, Qiulun Lu, Zhonglin Xie, Ming‐Hui Zou, Shengnan Wu, Qilong Wang, Ye Ding, Zejun Ma, Meng Du and Yu Qiu and has published in prestigious journals such as Circulation, Nature Communications and Diabetes.

In The Last Decade

Xiaoxiang Mao

14 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxiang Mao China 10 602 301 220 152 142 15 903
Zhuo-Wei Hu China 13 466 0.8× 252 0.8× 149 0.7× 114 0.8× 78 0.5× 17 877
Baohua Yang China 15 504 0.8× 93 0.3× 193 0.9× 138 0.9× 112 0.8× 32 815
Brendan Gongol United States 15 606 1.0× 150 0.5× 144 0.7× 66 0.4× 88 0.6× 23 952
Xiaoban Xin United States 10 392 0.7× 349 1.2× 128 0.6× 96 0.6× 150 1.1× 13 911
Haocheng Lu United States 17 514 0.9× 247 0.8× 114 0.5× 90 0.6× 126 0.9× 39 1.1k
Traci Marin United States 16 589 1.0× 148 0.5× 138 0.6× 65 0.4× 89 0.6× 20 930
Michael D. Wetzel United States 15 416 0.7× 277 0.9× 317 1.4× 123 0.8× 54 0.4× 23 1.1k
Xiaoding Wang China 12 316 0.5× 164 0.5× 76 0.3× 193 1.3× 127 0.9× 16 700
Jiao Mu China 17 522 0.9× 154 0.5× 150 0.7× 164 1.1× 36 0.3× 37 931

Countries citing papers authored by Xiaoxiang Mao

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiang Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiang Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiang Mao more than expected).

Fields of papers citing papers by Xiaoxiang Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiang Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiang Mao. The network helps show where Xiaoxiang Mao may publish in the future.

Co-authorship network of co-authors of Xiaoxiang Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiang Mao. A scholar is included among the top collaborators of Xiaoxiang Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiang Mao. Xiaoxiang Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhong, Yi, Pengfei Zhang, Xiaoxiang Mao, et al.. (2025). Ring Finger Protein 2 Promotes Oxidative Stress and Mitochondrial Dysfunction in Doxorubicin‐Induced Cardiotoxicity Via the Mercaptopyruvate Sulfurtransferase/Hydrogen Sulfide Pathway. Journal of the American Heart Association. 14(16). e041440–e041440.
2.
Mao, Xiaoxiang, Yi Zhong, Ru Chen, et al.. (2023). Kruppel-like factor 14 ameliorated obesity and related metabolic disorders by promoting adipose tissue browning. American Journal of Physiology-Endocrinology and Metabolism. 325(6). E744–E754. 1 indexed citations
3.
Du, Meng, Liu Yang, Bing Liu, et al.. (2021). Inhibition of NFAT suppresses foam cell formation and the development of diet‐induced atherosclerosis. The FASEB Journal. 35(10). e21951–e21951. 10 indexed citations
4.
Yi, Wei, et al.. (2021). Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis. American Journal of Physiology-Endocrinology and Metabolism. 320(5). E925–E937. 47 indexed citations
5.
Du, Meng, Xiaojing Wang, Yuan Lin, et al.. (2020). Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology. 73(6). 1333–1346. 29 indexed citations
6.
Mao, Xiaoxiang, Dandan Huang, Meng Du, et al.. (2020). Enoyl coenzyme A hydratase 1 combats obesity and related metabolic disorders by promoting adipose tissue browning. American Journal of Physiology-Endocrinology and Metabolism. 318(3). E318–E329. 12 indexed citations
7.
Liu, Baoqing, Xiaoxiang Mao, Dandan Huang, Fei Li, & Nianguo Dong. (2019). <p>Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 801–811. 13 indexed citations
8.
Du, Meng, Xiaojing Wang, Xiaoxiang Mao, et al.. (2019). Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. Theranostics. 9(16). 4688–4703. 33 indexed citations
9.
Liu, Chang, Shu Yan, Yilong Wang, et al.. (2019). Poly(ADP-ribose) Polymerase-1 is required for hepatocyte proliferation and liver regeneration in mice. Biochemical and Biophysical Research Communications. 511(3). 531–535. 9 indexed citations
10.
Huang, Dandan, et al.. (2019). The novel adipokine CTRP5 is a negative regulator of white adipose tissue browning. Biochemical and Biophysical Research Communications. 510(3). 388–394. 9 indexed citations
11.
Tan, Xin, Lizhi Hu, Long Chen, et al.. (2019). Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy. Diabetes. 68(11). 2063–2073. 45 indexed citations
12.
Huang, Dandan, Xiaoxiang Mao, Jiangtong Peng, et al.. (2019). Role of adipokine zinc-α2-glycoprotein in coronary heart disease. American Journal of Physiology-Endocrinology and Metabolism. 317(6). E1055–E1062. 7 indexed citations
13.
14.
Du, Meng, Yuan Lin, Xin Tan, et al.. (2017). The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nature Communications. 8(1). 2049–2049. 213 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuo-Wei Hu Breakdown of academic impact, for papers by Baohua Yang Breakdown of academic impact, for papers by Brendan Gongol Breakdown of academic impact, for papers by Xiaoban Xin Breakdown of academic impact, for papers by Haocheng Lu Breakdown of academic impact, for papers by Traci Marin Breakdown of academic impact, for papers by Michael D. Wetzel Breakdown of academic impact, for papers by Xiaoding Wang Breakdown of academic impact, for papers by Jiao Mu
Rankless by CCL
2026